Bioject®ZetaJet™ to be Utilized by Publix for Flu Season Immunizations

52 stores in the Southeast to begin providing needle-free immunizations in September

PORTLAND, Ore.--()--Bioject Medical Technologies Inc. (OTCBB:BJCT), a leading developer of needle-free injection therapy systems, announced today that beginning in September 2011, select Publix Super Markets (Publix) in the Southeast region will be offering flu season immunizations utilizing the Bioject®ZetaJet™. Publix will be conducting evaluations in 52 stores in Florida, Georgia, Alabama and South Carolina.

“We are pleased that Publix has chosen to offer the Bioject®ZetaJet™ spring-powered device, Bioject’s latest advance in needle-free delivery, for this year’s flu immunizations,” said Dr. Richard Stout, Executive Vice President and Chief Medical Officer of Bioject. “The ergonomically- designed Bioject®ZetaJet™ provides patients a convenient alternative to the needle and syringe for the administration of the flu vaccine,” added Dr. Stout.

The Bioject®ZetaJet™, Bioject’s latest advance in needle-free delivery systems, consists of two components, the portable injector and an auto-disabling disposable syringe. It is intended to deliver vaccines and injectable medications up to 0.5 mL either subcutaneously or intramuscularly. The syringe assembly has a unique “auto-disable” feature that prevents its re-use.

About Bioject

Bioject Medical Technologies Inc., based in Portland, Oregon, USA, is an innovative developer and manufacturer of needle-free injection therapy systems (NFITS). NFITS provide an empowering technology and work by forcing medication at high speed through a tiny orifice held against the skin. This creates a fine stream of high-pressure fluid penetrating the skin and depositing medication in the tissue beneath. Bioject is focused on developing mutually beneficial agreements with leading pharmaceutical, biotechnology, and veterinary companies, as well as research, global health and government organizations. For more information about Bioject, visit www.bioject.com.

About Publix

Founded in 1930, Publix Super Markets is the largest and fastest-growing employee-owned supermarket chain in the United States. Publix and our associates excel in community involvement, volunteerism and a commitment to our market areas and beyond. Publix's commitment to diversity has contributed to their success in being a great place to work and shop. For more information about Publix, visit www.publix.com

Contacts

Bioject Medical Technologies Inc.
President and CEO
Ralph Makar, 503-692-8001 ext. 4137
or
Executive Vice President and Chief Medical Officer
Dr. Richard Stout, 503-692-8001 ext. 4130

Contacts

Bioject Medical Technologies Inc.
President and CEO
Ralph Makar, 503-692-8001 ext. 4137
or
Executive Vice President and Chief Medical Officer
Dr. Richard Stout, 503-692-8001 ext. 4130